Abiopharma

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: SpringWorks Therapeutics, Inc. - common stock.

Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy

ArriVent Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants

Intel Core Ultra 9: Arrow Lake’s AI Powerhouse and Efficiency Champion

The Latest on XMP: Next-Gen Memory Overclocking & AI Boosts

Night Has Fallen: Everything We Know About the Fourth Mike Banning Thriller

Ceasing to be a substantial holder

The Latest News On Ethereum As Big Money Keeps Buying

New Form 4 - Phreesia, Inc. Filed: 2025-07-01 AccNo: 0001127602-25-018423 Size: 7 KB

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

New Form 4 - Oruka Therapeutics, Inc. Filed: 2025-07-01 AccNo: 0001062993-25-012406 Size: 5 KB